血管アクセスデバイス市場 : 2028年までの世界予測

Report Overview

The global vascular access device market is projected to reach USD 7.9 billion by 2028 from USD 5.6 billion in 2023, at a CAGR of 7.0% during the forecast period. Growth in the vascular access device market can primarily be attributed to factors such as the growing prevalence of lifestyle diseases, increasing number of chemotherapy procedures, and growing use of vascular access device in pediatric patients. However, the high cost involved in the placement and maintenance of vascular access device is expected to limit the growth of the vascular access device market to a certain extent during the forecast period.

In 2023, the central vascular access device segment is projected to account for the largest share of the vascular access device market

By type, vascular access device market is segmented into there are peripheral access device, central vascular access device, and accessories holding a significant portion. The central vascular access device segment is is projected to account for the largest share of the global vascular access device market in 2023. Factors such as broad usage of central vascular access device in chemotherapy and in the medication of cardiovascular disorders and chronic kidney disorders.

Drug administration is projected to account for the largest share of the vascular access device market in 2023

By application, vascular access device market is segmented into drug administration, fluid and nutrition administration,blood transfusion, and diagnostic & testing. The drug administration segment is is projected to account for the largest share of the global vascular access device market in 2023.Factors such as high use of vascular access device for drug administration, specially for the treatment of infections and cancer are driving the market growth.

By end user, hospitals accounted for the largest share of the market in 2022
By end users, vascular access device market is segmented into hospitals, clinics & ambulatory centers, and other end users (nursing homes, laboratories, diagnostic & imaging centers, and home healthcare agencies). In 2022, hospitals accounted for the largest market share. Factors suc as majority of vascular procedures are performed in hospital settings and also emergency care in hospitals needs VADs for blood transfusion and administration of various drugs.

By region, North America is projected to account for the largest share of the vascular access device market
By region,North America accounted for the largest share of the vascular access device market in 2023. Factors such as the presence of key players, a supportive reimbursement framework, and significant government investments in cutting-edge medical devices,rising healthcare costs, government initiatives, and an increase in disposable income are contributing to the market’s growth in North America.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–55%, Tier 2–25%, and Tier 3–20%
• By Designation – C-level–43%, Director-level–32%, Others–25%
• By Region – North America–38%, Europe–23%, Asia Pacific–29%, Rest of the World- 10%

Key players in the vascular access device Market
The prominent players in this market are Becton, Dickinson and Company (US), ICU Medical, Inc. (US), Teleflex Incorporated (US), B. Braun SE (Germany), AngioDynamics, Inc. (US), Terumo Corporation (Japan), Nipro Medical Corporation (Japan), Medtronic (Ireland), Amecath (Egypt),Romsons (India), PRODIMED (France),Cook Medical (US), Access Vascular, Inc. (US), Medical Components, Inc. (US), Vygon (France), 3M (US), Argon Medical Devices (US), Guangdong Baihe Medical Technology Co., Ltd. (China), pfm medical (Germany), Medi-Tech Devices Pvt Ltd (India), Medline Industries, LP (US), Kimal (UK), Deltamed (Italy), Newtech Medical Devices (India) and Shanghai Puyi Medical Instruments Co., Ltd (China).

Research Coverage:
The report analyzes the vascular access device Market and aims at estimating the market size and future growth potential of this market based on various segments such as type, application and end user. The report also includes a product portfolio matrix of various vascular access device products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, service offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
Analysis of key drivers (growing prevalence of lifestyle diseases,increasing number of chemotherapy procedures,increasing use of vascular access device in pediatric patients), restraints (high costs involved in the placement and maintenance of vascular access device,product recalls and failures), opportunities (technological advancements and growth in the number of hospitals) and challenges (Shortage of skilled professionals and risks associated with vascular access device) influencing the growth of vascular access device market.

• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global vascular access device Market. The report analyzes this market by type, applications and end user.
• Service Enhancement/Innovation: Detailed insights on upcoming trends in the global vascular access device Market
• Market Development: Comprehensive information on the lucrative emerging markets by applications, type and end user.
• Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global vascular access device Market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product and service offerings, company evaluation quadrant, and capabilities of leading players in the global vascular access device Market.

Table of Contents

1 INTRODUCTION 25
1.1 STUDY OBJECTIVES 25
1.2 MARKET DEFINITION 25
1.2.1 INCLUSIONS & EXCLUSIONS 26
1.2.2 MARKETS COVERED 26
FIGURE 1 VASCULAR ACCESS DEVICES MARKET SEGMENTATION 26
1.2.3 REGIONAL SEGMENTATION 27
1.2.4 YEARS CONSIDERED 27
1.3 CURRENCY 27
1.4 STAKEHOLDERS 28
1.5 SUMMARY OF CHANGES 28
2 RESEARCH METHODOLOGY 29
2.1 RESEARCH DATA 29
FIGURE 2 RESEARCH DESIGN 29
2.1.1 SECONDARY DATA 30
2.1.1.1 Key data from secondary sources 31
2.1.2 PRIMARY DATA 31
FIGURE 3 PRIMARY SOURCES 32
2.1.2.1 Key data from primary sources 33
2.1.2.2 Key industry insights 33
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS 34
2.2 MARKET SIZE ESTIMATION 34
FIGURE 5 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 35
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: BECTON, DICKINSON AND COMPANY 35
FIGURE 7 SEGMENTAL EXTRAPOLATION: GLOBAL VASCULAR ACCESS DEVICES MARKET (2022) 36
FIGURE 8 BOTTOM-UP APPROACH: GLOBAL VASCULAR ACCESS DEVICES MARKET (2022) 37
FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 38
FIGURE 10 CAGR PROJECTIONS 38
FIGURE 11 TOP-DOWN APPROACH 39
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 40
FIGURE 12 DATA TRIANGULATION METHODOLOGY 40
2.4 STUDY ASSUMPTIONS 41
2.5 LIMITATIONS 41
2.5.1 METHODOLOGY-RELATED LIMITATIONS 41
2.6 RISK ASSESSMENT 41
2.7 VASCULAR ACCESS DEVICES MARKET: RECESSION IMPACT 41
3 EXECUTIVE SUMMARY 43
FIGURE 13 VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 43
FIGURE 14 VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 44
FIGURE 15 VASCULAR ACCESS DEVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 44
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF VASCULAR ACCESS DEVICES MARKET 45
4 PREMIUM INSIGHTS 46
4.1 VASCULAR ACCESS DEVICES MARKET OVERVIEW 46
FIGURE 17 GROWING PREVALENCE OF LIFESTYLE DISEASES TO DRIVE MARKET GROWTH 46
4.2 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER 47
FIGURE 18 HOSPITALS ACCOUNTED FOR LARGEST SHARE OF APAC MARKET IN 2022 47
4.3 VASCULAR ACCESS DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 48
FIGURE 19 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 48
4.4 REGIONAL MIX: VASCULAR ACCESS DEVICES MARKET (2021–2028) 49
FIGURE 20 ASIA PACIFIC MARKET TO GROW AT HIGHEST RATE DURING FORECAST PERIOD 49
4.5 VASCULAR ACCESS DEVICES MARKET: DEVELOPED VS. EMERGING ECONOMIES 49
FIGURE 21 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 49
5 MARKET OVERVIEW 50
5.1 INTRODUCTION 50
5.2 MARKET DYNAMICS 50
FIGURE 22 VASCULAR ACCESS DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 50
5.2.1 DRIVERS 51
5.2.1.1 Growing prevalence of lifestyle diseases 51
5.2.1.2 Increasing number of chemotherapy procedures 51
5.2.1.3 Growing use of vascular access devices in pediatric patients 52
5.2.2 RESTRAINTS 52
5.2.2.1 High cost associated with placement and maintenance of vascular access devices 52
5.2.2.2 Product recalls and failures 52
5.2.3 OPPORTUNITIES 53
5.2.3.1 Technological advancements 53
5.2.3.2 Growth in number of hospitals 54
5.2.4 CHALLENGES 54
5.2.4.1 Shortage of skilled professionals 54
5.2.4.2 Risks associated with vascular access devices 54
5.3 INDUSTRY TRENDS 55
5.3.1 MINIMALLY INVASIVE VASCULAR ACCESS PROCEDURES 55
5.3.2 INNOVATIONS IN CATHETER MATERIALS AND COATINGS 55
5.4 VALUE CHAIN ANALYSIS 56
FIGURE 23 MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 56
5.5 ECOSYSTEM MAPPING 57
5.5.1 ROLE IN ECOSYSTEM 57
5.6 PORTER’S FIVE FORCES ANALYSIS 58
5.6.1 THREAT OF NEW ENTRANTS 58
5.6.2 INTENSITY OF COMPETITIVE RIVALRY 58
5.6.3 BARGAINING POWER OF BUYERS 58
5.6.4 BARGAINING POWER OF SUPPLIERS 58
5.6.5 THREAT OF SUBSTITUTES 58
6 VASCULAR ACCESS DEVICES MARKET, BY TYPE 59
6.1 INTRODUCTION 60
TABLE 1 VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 60
6.2 CENTRAL VASCULAR ACCESS DEVICES 60
TABLE 2 CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 61
TABLE 3 CENTRAL VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 61
6.2.1 PERIPHERALLY INSERTED CENTRAL CATHETERS 62
6.2.1.1 Complications associated with PICCs to limit adoption in coming years 62
TABLE 4 PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 62
6.2.2 TUNNELED CATHETERS 63
6.2.2.1 Advantages of tunneled catheters such as lower risk of infection and lower chances of accidental removal to boost demand 63
TABLE 5 TUNNELED CATHETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 63
6.2.3 NON-TUNNELED CATHETERS 64
6.2.3.1 High risk of infection to limit market growth 64
TABLE 6 NON-TUNNELED CATHETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 64
6.2.4 IMPLANTED PORTS 65
6.2.4.1 Lowest risk of infection associated with implanted ports to support growth 65
TABLE 7 IMPLANTED PORTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 65
6.3 PERIPHERAL VASCULAR ACCESS DEVICES 66
TABLE 8 PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 66
TABLE 9 PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 67
6.3.1 PERIPHERAL SHORT DEVICES 67
6.3.1.1 Ability of peripheral short devices to only administer select types of medication to hamper growth 67
TABLE 10 PERIPHERAL SHORT DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 68
6.3.2 PERIPHERAL MIDLINE DEVICES 68
6.3.2.1 Need for trained nurses for procedures to restrict growth 68
TABLE 11 PERIPHERAL MIDLINE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 69
6.3.3 BUTTERFLY/WINGED STEEL NEEDLES 69
6.3.3.1 Wide usage of winged steel needles in blood sampling and diagnosis to propel growth 69
TABLE 12 BUTTERFLY/WINGED STEEL NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 70
6.4 ACCESSORIES 70
6.4.1 RECURRENT NEED FOR ACCESSORIES TO BOOST MARKET 70
TABLE 13 VASCULAR ACCESS DEVICE ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 71
7 VASCULAR ACCESS DEVICES MARKET, BY APPLICATION 72
7.1 INTRODUCTION 73
TABLE 14 VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 73
7.2 DRUG ADMINISTRATION 73
7.2.1 HIGH USAGE OF VASCULAR ACCESS DEVICES FOR DRUG ADMINISTRATION TO BOOST SEGMENTAL GROWTH 73
TABLE 15 VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 74
7.3 FLUID & NUTRITION ADMINISTRATION 74
7.3.1 GROWING USE OF PERIPHERAL VASCULAR ACCESS DEVICES FOR SHORT-TERM NUTRITIONAL THERAPY TO SUPPORT MARKET 74
TABLE 16 VASCULAR ACCESS DEVICES MARKET FOR FLUID & NUTRITION ADMINISTRATION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 75
7.4 BLOOD TRANSFUSION 75
7.4.1 FREQUENT NEED FOR BLOOD TRANSFUSION IN TREATMENT OF VARIOUS CONDITIONS TO BOOST GROWTH 75
TABLE 17 VASCULAR ACCESS DEVICES MARKET FOR BLOOD TRANSFUSION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 76
7.5 DIAGNOSTICS & TESTING 76
7.5.1 GROWING POPULARITY OF PERIPHERAL LINES FOR DIAGNOSTIC & TESTING APPLICATIONS TO DRIVE MARKET GROWTH 76
TABLE 18 VASCULAR ACCESS DEVICES MARKET FOR DIAGNOSTICS & TESTING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 77
8 VASCULAR ACCESS DEVICES MARKET, BY END USER 78
8.1 INTRODUCTION 79
TABLE 19 VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 79
8.2 HOSPITALS 79
8.2.1 HIGH DEMAND FOR VASCULAR ACCESS DEVICES IN HOSPITAL SETTINGS TO BOOST MARKET 79
TABLE 20 VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION) 80
8.3 CLINICS & AMBULATORY CARE CENTERS 80
8.3.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO SUPPORT MARKET GROWTH 80
TABLE 21 VASCULAR ACCESS DEVICES MARKET FOR CLINICS & AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION) 81
8.4 OTHER END USERS 81
TABLE 22 VASCULAR ACCESS DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 82
9 VASCULAR ACCESS DEVICES MARKET, BY REGION 83
9.1 INTRODUCTION 84
TABLE 23 VASCULAR ACCESS DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 84
9.2 NORTH AMERICA 84
9.2.1 NORTH AMERICA: RECESSION IMPACT 84
FIGURE 24 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET SNAPSHOT 85
TABLE 24 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 25 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 86
TABLE 26 NORTH AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 86
TABLE 27 NORTH AMERICA: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 87
TABLE 28 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 87
TABLE 29 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 87
9.2.2 US 88
9.2.2.1 High prevalence of chronic diseases to drive market growth 88
TABLE 30 INDICATIVE LIST OF CLINICAL TRIALS CONDUCTED 88
TABLE 31 US: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 89
TABLE 32 US: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 89
TABLE 33 US: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 89
TABLE 34 US: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 90
TABLE 35 US: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 90
9.2.3 CANADA 90
9.2.3.1 Increasing number of minimally invasive procedures to support market growth 90
TABLE 36 CANADA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 91
TABLE 37 CANADA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 91
TABLE 38 CANADA: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 92
TABLE 39 CANADA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 92
TABLE 40 CANADA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 92
9.3 EUROPE 93
9.3.1 EUROPE: RECESSION IMPACT 93
TABLE 41 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 42 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 94
TABLE 43 EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 94
TABLE 44 EUROPE: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 94
TABLE 45 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 95
TABLE 46 EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 95
9.3.2 GERMANY 95
9.3.2.1 Growing geriatric and obese populations to contribute to market growth 95
TABLE 47 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 96
TABLE 48 GERMANY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 96
TABLE 49 GERMANY: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 97
TABLE 50 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 97
TABLE 51 GERMANY: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 97
9.3.3 UK 98
9.3.3.1 Increasing incidence of coronary heart disease to support market growth 98
TABLE 52 UK: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 98
TABLE 53 UK: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 99
TABLE 54 UK: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 99
TABLE 55 UK: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 99
TABLE 56 UK: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 100
9.3.4 FRANCE 100
9.3.4.1 Strong government support and favorable strategies & initiatives to drive market growth 100
TABLE 57 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 100
TABLE 58 FRANCE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 101
TABLE 59 FRANCE: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 101
TABLE 60 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 102
TABLE 61 FRANCE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 102
9.3.5 ITALY 102
9.3.5.1 Strong healthcare policies by government to propel growth 102
TABLE 62 ITALY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 103
TABLE 63 ITALY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 103
TABLE 64 ITALY: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 104
TABLE 65 ITALY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 104
TABLE 66 ITALY: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 104
9.3.6 SPAIN 105
9.3.6.1 Growing geriatric population to increase demand for vascular access devices 105
TABLE 67 SPAIN: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 105
TABLE 68 SPAIN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 105
TABLE 69 SPAIN: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 106
TABLE 70 SPAIN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 106
TABLE 71 SPAIN: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 106
9.3.7 REST OF EUROPE 107
TABLE 72 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 107
TABLE 73 REST OF EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 108
TABLE 74 REST OF EUROPE: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 108
TABLE 75 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 109
TABLE 76 REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 109
9.4 ASIA PACIFIC 109
9.4.1 ASIA PACIFIC: RECESSION IMPACT 110
FIGURE 25 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET SNAPSHOT 111
TABLE 77 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 78 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 112
TABLE 79 ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 112
TABLE 80 ASIA PACIFIC: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 113
TABLE 81 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 113
TABLE 82 ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 113
9.4.2 JAPAN 114
9.4.2.1 Large geriatric population to support market growth 114
TABLE 83 JAPAN: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 114
TABLE 84 JAPAN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 115
TABLE 85 JAPAN: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 115
TABLE 86 JAPAN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 116
TABLE 87 JAPAN: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 116
9.4.3 CHINA 116
9.4.3.1 Growing target patient population to drive market growth 116
TABLE 88 CHINA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 117
TABLE 89 CHINA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 117
TABLE 90 CHINA: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 118
TABLE 91 CHINA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 118
TABLE 92 CHINA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 118
9.4.4 INDIA 119
9.4.4.1 Increasing prevalence of diabetes to drive adoption of vascular access devices 119
TABLE 93 INDIA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 119
TABLE 94 INDIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 120
TABLE 95 INDIA: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 120
TABLE 96 INDIA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 121
TABLE 97 INDIA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 121
9.4.5 REST OF ASIA PACIFIC 121
TABLE 98 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 122
TABLE 99 REST OF ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 122
TABLE 100 REST OF ASIA PACIFIC: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 123
TABLE 101 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 123
TABLE 102 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 123
9.5 REST OF THE WORLD 124
9.5.1 REST OF THE WORLD: RECESSION IMPACT 124
TABLE 103 REST OF THE WORLD: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 124
TABLE 104 REST OF THE WORLD: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 125
TABLE 105 REST OF THE WORLD: CENTRAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 125
TABLE 106 REST OF THE WORLD: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 126
TABLE 107 REST OF THE WORLD: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 126
10 COMPETITIVE LANDSCAPE 127
10.1 OVERVIEW 127
10.2 STRATEGIES ADOPTED BY KEY PLAYERS 127
TABLE 108 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS 127
10.3 REVENUE SHARE ANALYSIS 130
FIGURE 26 REVENUE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET (2020–2022) 130
10.4 MARKET SHARE ANALYSIS 130
FIGURE 27 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET (2022) 131
10.5 MARKET RANKING ANALYSIS 131
FIGURE 28 VASCULAR ACCESS DEVICES MARKET: KEY PLAYER RANKING, 2022 132
10.6 COMPANY EVALUATION MATRIX 133
10.6.1 STARS 133
10.6.2 EMERGING LEADERS 133
10.6.3 PERVASIVE PLAYERS 133
10.6.4 PARTICIPANTS 133
FIGURE 29 VASCULAR ACCESS DEVICES MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022) 134
10.7 COMPANY EVALUATION MATRIX FOR SMES/START-UPS 135
10.7.1 PROGRESSIVE COMPANIES 135
10.7.2 DYNAMIC COMPANIES 135
10.7.3 STARTING BLOCKS 135
10.7.4 RESPONSIVE COMPANIES 135
FIGURE 30 VASCULAR ACCESS DEVICES MARKET: COMPANY EVALUATION MATRIX FOR SMES/START-UPS (2022) 136
10.8 COMPANY FOOTPRINT ANALYSIS 137
TABLE 109 COMPANY FOOTPRINT: VASCULAR ACCESS DEVICES MARKET (2022) 137
10.8.1 COMPANY FOOTPRINT, BY TYPE 138
TABLE 110 TYPE FOOTPRINT: VASCULAR ACCESS DEVICES MARKET (2022) 138
10.8.2 COMPANY FOOTPRINT, BY REGION 139
TABLE 111 REGIONAL FOOTPRINT: VASCULAR ACCESS DEVICES MARKET (2022) 139
10.9 COMPETITIVE SCENARIO 140
10.9.1 PRODUCT LAUNCHES 140
TABLE 112 PRODUCT LAUNCHES, JANUARY 2019–JULY 2023 140
10.9.2 DEALS 141
TABLE 113 DEALS, JANUARY 2019–JULY 2023 141
10.9.3 OTHER DEVELOPMENTS 142
TABLE 114 OTHER DEVELOPMENTS, JANUARY 2019–JULY 2023 142
11 COMPANY PROFILES 143
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
11.1 KEY PLAYERS 143
11.1.1 BECTON, DICKINSON AND COMPANY 143
TABLE 115 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 143
FIGURE 31 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022) 144
11.1.2 TELEFLEX INCORPORATED 148
TABLE 116 TELEFLEX INCORPORATED: BUSINESS OVERVIEW 148
FIGURE 32 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2022) 149
11.1.3 ICU MEDICAL, INC. 152
TABLE 117 ICU MEDICAL, INC.: BUSINESS OVERVIEW 152
FIGURE 33 ICU MEDICAL, INC.: COMPANY SNAPSHOT (2022) 153
11.1.4 B. BRAUN SE 156
TABLE 118 B. BRAUN SE: BUSINESS OVERVIEW 156
FIGURE 34 B. BRAUN SE: COMPANY SNAPSHOT (2022) 157
11.1.5 ANGIODYNAMICS, INC. 160
TABLE 119 ANGIODYNAMICS, INC.: BUSINESS OVERVIEW 160
FIGURE 35 ANGIODYNAMICS, INC.: COMPANY SNAPSHOT (2022) 161
11.1.6 TERUMO CORPORATION 163
TABLE 120 TERUMO CORPORATION: BUSINESS OVERVIEW 163
FIGURE 36 TERUMO CORPORATION: COMPANY SNAPSHOT (2023) 164
11.1.7 NIPRO MEDICAL CORPORATION 165
TABLE 121 NIPRO MEDICAL CORPORATION: BUSINESS OVERVIEW 165
FIGURE 37 NIPRO MEDICAL CORPORATION: COMPANY SNAPSHOT (2022) 165
11.1.8 MEDTRONIC 167
TABLE 122 MEDTRONIC: BUSINESS OVERVIEW 167
FIGURE 38 MEDTRONIC: COMPANY SNAPSHOT (2022) 168
11.1.9 AMECATH 170
TABLE 123 AMECATH: BUSINESS OVERVIEW 170
11.1.10 ROMSONS 172
TABLE 124 ROMSONS: BUSINESS OVERVIEW 172
11.1.11 PRODIMED 173
TABLE 125 PRODIMED: BUSINESS OVERVIEW 173
11.1.12 COOK MEDICAL 174
TABLE 126 COOK MEDICAL: BUSINESS OVERVIEW 174
11.1.13 ACCESS VASCULAR, INC. 175
TABLE 127 ACCESS VASCULAR, INC.: BUSINESS OVERVIEW 175
11.1.14 MEDICAL COMPONENTS, INC. 176
TABLE 128 MEDICAL COMPONENTS, INC.: BUSINESS OVERVIEW 176
11.1.15 VYGON 178
TABLE 129 VYGON: BUSINESS OVERVIEW 178
11.2 OTHER COMPANIES 180
11.2.1 3M 180
11.2.2 ARGON MEDICAL DEVICES 181
11.2.3 GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD. 181
11.2.4 PFM MEDICAL 182
11.2.5 MEDI-TECH DEVICES PVT. LTD. 183
11.2.6 MEDLINE INDUSTRIES, LP 183
11.2.7 KIMAL 184
11.2.8 DELTA MED 184
11.2.9 NEWTECH MEDICAL DEVICES 185
11.2.10 SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD. 185
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
 
12 APPENDIX 186
12.1 DISCUSSION GUIDE 186
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 190
12.3 CUSTOMIZATION OPTIONS 192
12.4 RELATED REPORTS 192
12.5 AUTHOR DETAILS 193